You are here

  • Home
  • Archive
  • Volume 61, Issue suppl 2
  • Adalimumab (a fully human anti-tumour necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials

Article Text

Article menu
Download PDFPDF
Clinical and radiological aspects of biologics
Adalimumab (a fully human anti-tumour necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials

https://doi.org/10.1136/ard.61.suppl_2.ii70

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.